Categories AlphaGraphs, Earnings, Health Care
Eli Lilly (LLY) Q3 2024 Earnings: Key financials and quarterly highlights
Eli Lilly and Company (NYSE: LLY) reported its third quarter 2024 earnings results today.
Worldwide revenue was $11.44 billion, up 20% compared to the same period a year ago.
GAAP net income was $970.3 million, or $1.07 per share, compared to a net loss of $57.4 million, or $0.06 per share, last year. Adjusted EPS was $1.18.
Revenue and earnings missed expectations, sending the stock plunging over 13% on Wednesday.
For fiscal year 2024, the company expects revenues of $45.4-46.0 billion, GAAP EPS of $12.05-12.55 and adjusted EPS of $13.02-13.52.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Important takeaways from Conagra Brands’ Q3 2025 report
Conagra Brands, Inc. (NYSE: CAG) has reported weaker-than-expected revenue and profit for the February quarter, with sales declining across all business segments amid softer demand and persistent supply challenges. The
Main takeaways from Lamb Weston’s (LW) Q3 2025 earnings report
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) jumped 9% on Thursday after the company delivered better-than-expected results for the third quarter of 2025 and reaffirmed its outlook for the
Summary: Tesla (TSLA) reports Q1 2025 production, deliveries
Tesla Inc. (NASDAQ: TSLA) has announced results of vehicle production and deliveries for the first quarter of 2025. The company also provided data on the deployment of energy storage products
